Promotion of Regular Oesophageal motility to Prevent regurgitation and Enhance nutrition intake in Long-stay ICU patients. A multicenter, Phase II, sham-controlled, randomized trial: The PROPEL Study
The PROPEL study represents an exciting collaboration between CERU and E-Motion Medical Ltd. to to assess the efficacy and safety of the E-Motion Systemâ„¢ on the promotion of GI motility in critically ill patients.
This trial is registered at ClinicalTrials.gov (NCT02515123).
Recruitment: Study participants will be recruited in 8-10 sites across Canada.
Start Date: Winter 2016